Showing results (501-510 of 1,813) with videos related to

Sort By:
Pageof 182
Transplantation and Cellular Therapy|August 11, 2021
Influence of Killer Immunoglobulin-Like Receptors and Somatic Mutations on Transplant Outcomes in Acute Myeloid LeukemiaSanghee Hong, Lisa Rybicki, Aiwen Zhang, et al.
Transplantation and Cellular Therapy|November 19, 2022
Characterization and Function of Cryopreserved Bone Marrow from Deceased Organ Donors: A Potential Viable Alternative Graft SourceBrian H Johnstone, John R Woods, W Scott Goebel, et al.
Transplantation and Cellular Therapy|November 19, 2022
Hematopoietic Stem Cell Transplantation Activity in China 2020-2021 During the SARS-CoV-2 Pandemic: A Report From the Chinese Blood and Marrow Transplantation Registry GroupLan-Ping Xu, Dao-Pei Lu, De-Pei Wu, et al.
Transplantation and Cellular Therapy|February 3, 2023
Clinical Benefit of Low-Dose Antithymocyte Globulin-Thymoglobulin as Graft-versus-Host Disease Prophylaxis in Patients Receiving Allogeneic Peripheral Blood Stem Cell Transplantation from HLA-Identical DonorsYuki Takeuchi, Kotaro Miyao, Shuto Negishi, et al.
Transplantation and Cellular Therapy|February 16, 2023
Advantages of Higher Busulfan Dose Intensity in Fludarabine-Combined Conditioning for Patients with Acute Myeloid Leukemia Undergoing Cord Blood TransplantationSho Shibata, Yasuyuki Arai, Tadakazu Kondo, et al.
Transplantation and Cellular Therapy|February 16, 2023
A Multiparameter Prognostic Risk Score of Chronic Graft-versus-Host Disease Based on CXCL10 and Plasmacytoid Dendritic Cell Levels in the Peripheral Blood at 3 Months after Allogeneic Hematopoietic Stem Cell TransplantationGabriella Chirumbolo, Michele Dicataldo, Martina Barone, et al.
Transplantation and Cellular Therapy|October 6, 2022
Pulmonary Manifestations and Vascular Changes in Pediatric Transplantation-Associated Thrombotic MicroangiopathyMichelle L Schoettler, Blachy D Saldana, Lisa Berkenkamp, et al.
Transplantation and Cellular Therapy|October 6, 2022
Response and Dynamics of Renal Function in Transplantation-Eligible Multiple Myeloma Patients Treated with a Novel Agent: The CAREMM-2201 StudyYaeni Kim, Sung-Soo Park, Young-Woo Jeon, et al.
Transplantation and Cellular Therapy|August 28, 2022
Impact of Cytogenetic Risk on Outcomes of Non-T-Cell-Depleted Haploidentical Hematopoietic Cell Transplantation in Patients with Relapsed or Refractory Acute Myeloid LeukemiaArnon Nagler, Myriam Labopin, Bhagirathbhai Dholaria, et al.
Transplantation and Cellular Therapy|December 13, 2021
Inhibition of IL-1 Receptor-Associated Kinase 1 Decreases Murine Acute Graft-versus-Host Disease While Preserving the Graft-versus-Lymphoma EffectJun Gao, Yan Xu, Sha Ma, et al.
Pageof 182